Case Report: Lenalidomide as a Second-Line Treatment for Bortezomib-Ineffective Nephrotic Syndrome Caused by LCDD: 2 Case Reports and a Literature Review

Background: Light-chain deposition disease (LCDD) is a rare systemic disorder characterized by the deposition of monoclonal light chains in organs. The kidney is a prominent target of light-chain deposition, with a median time to end-stage renal disease (ESRD) of 2.7 years and 5-year ESRD-free survi...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhang, Xin, Yu, Xiao-juan, Wang, Su-xia, Zhou, Fu-de, Zhao, Ming-hui
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2021
Materias:
Medicine
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8531272/
https://www.ncbi.nlm.nih.gov/pubmed/34692719
http://dx.doi.org/10.3389/fmed.2021.706971

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8531272/
https://www.ncbi.nlm.nih.gov/pubmed/34692719
http://dx.doi.org/10.3389/fmed.2021.706971

Ejemplares similares